Sequential anti-CD19 directed chimeric antigen receptor modified T-cell therapy (CART19) and PD-1 blockade with pembrolizumab in patients with relapsed or refractory B-cell non-Hodgkin lymphomas Meeting Abstract
| Authors: | Chong, E. A.; Svoboda, J.; Nasta, S. D.; Landsburg, D. J.; Winchell, N.; Napier, E.; Mato, A. R.; Melenhorst, J. J.; Ruella, M.; Lacey, S. F.; June, C. H.; Schuster, S. J. |
| Abstract Title: | Sequential anti-CD19 directed chimeric antigen receptor modified T-cell therapy (CART19) and PD-1 blockade with pembrolizumab in patients with relapsed or refractory B-cell non-Hodgkin lymphomas |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454842803219 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-119502 |
| Notes: | Meeting Abstract: 4198 -- Source: Wos |
